Title:
マイトジェン活性化プロテインキナーゼ-活性化プロテインキナーゼ-2阻害剤としてのアミノシアノピリジンの使用法
Document Type and Number:
Japanese Patent JP2006512338
Kind Code:
A
Abstract:
A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject an anminocyanopyridine MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.
Inventors:
Rainhard, Emily Jay
Corojay, Stephen A.
Anderson, David Earle
Stelle, Nathan W
Vernier, William Eff
Lee, Len F
Hedge, Shridher Gee
Corojay, Stephen A.
Anderson, David Earle
Stelle, Nathan W
Vernier, William Eff
Lee, Len F
Hedge, Shridher Gee
Application Number:
JP2004560746A
Publication Date:
April 13, 2006
Filing Date:
December 09, 2003
Export Citation:
Assignee:
Pharmacia Corporation
International Classes:
A61K31/435; A61K31/4162; A61K31/4164; A61K31/4188; A61K31/4355; A61K31/436; A61K31/4365; A61K31/437; A61K31/4375; A61K31/44; A61K31/4418; A61K31/443; A61K31/4436; A61K31/4439; A61K31/4545; A61K31/455; A61K31/47; A61K31/4706; A61K31/4709; A61K31/472; A61K31/473; A61K31/4745; A61K31/4748; A61K31/5377; A61K31/5415; A61K31/55; A61K31/69; A61K31/706; A61P1/00; A61P1/02; A61P1/04; A61P3/10; A61P7/06; A61P9/10; A61P11/00; A61P11/06; A61P13/12; A61P15/02; A61P17/00; A61P17/02; A61P17/06; A61P19/02; A61P19/04; A61P19/06; A61P21/04; A61P25/00; A61P25/04; A61P25/06; A61P25/28; A61P27/02; A61P29/00; A61P31/10; A61P31/12; A61P31/18; A61P31/22; A61P35/00; A61P37/02; A61P43/00; C07D491/052; C07D491/153; C07D507/00; C07D213/85; C07D215/54; C07D217/26; C07D221/04; C07D221/06; C07D401/04; C07D405/04; C07D405/14; C07D409/04; C07D409/14; C07D417/14; C07D471/04; C07D491/048; C07D495/04; C07D513/04; C07H15/26
Attorney, Agent or Firm:
Kazuo Shamoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hiroko Ejiri
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hiroko Ejiri